HUTCHMED (China) Ltd Files 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Jan 28, 2025 · CIK: 1648257
| Field | Detail |
|---|---|
| Company | Hutchmed (China) LTD (HMDCF) |
| Form Type | 6-K |
| Filed Date | Jan 28, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, corporate-update, foreign-private-issuer
TL;DR
HUTCHMED (China) Ltd filed a routine 6-K, confirming its status and previous name change.
AI Summary
HUTCHMED (China) Limited filed a Form 6-K on January 28, 2025, reporting as a foreign private issuer. The filing indicates the company previously operated under the name Hutchison China MediTech Ltd before changing its name on July 16, 2015. The company is based in Hong Kong and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides an update on HUTCHMED's regulatory status and corporate information as a foreign private issuer, which is important for investors tracking the company's compliance and structure.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain new financial or operational information that would typically indicate a change in risk.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Registrant
- Hutchison China MediTech Ltd (company) — Former company name
- 20150716 (date) — Date of name change
- 20250128 (date) — Filing date
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the company has made or is required to make public pursuant to the laws of its home country or that it has filed or will file with a stock exchange.
When was HUTCHMED (China) Limited's name changed?
HUTCHMED (China) Limited's name was changed on July 16, 2015.
What industry does HUTCHMED (China) Limited operate in?
HUTCHMED (China) Limited operates in the Pharmaceutical Preparations industry, with a Standard Industrial Classification code of 2834.
Where is HUTCHMED (China) Limited's principal executive office located?
The principal executive offices of HUTCHMED (China) Limited are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
Does HUTCHMED (China) Limited file annual reports under Form 20-F or 40-F?
The filing indicates that HUTCHMED (China) Limited files annual reports under Form 20-F.
Filing Stats: 158 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2025-01-28 06:03:25
Filing Documents
- hcm-20250128x6k.htm (6-K) — 19KB
- hcm-20250128xex99d1.htm (EX-99.1) — 27KB
- hcm-20250128xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-25-000006.txt ( ) — 53KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of January 2025 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Overseas regulatory announcement on disposal transaction 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: January 28, 2025 3